Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (61-70 of 227) with videos related to

Pageof 23
Sort By:
Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.
Blood Advances|July 3, 2025
Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation StudyJohn C Panetta, Aimee C Talleur, Swati Naik, et al.
JCI Insight|November 5, 2020
MyD88/CD40 signaling retains CAR T cells in a less differentiated stateBrooke Prinzing, Patrick Schreiner, Matthew Bell, et al.
Cancer Discovery|August 13, 2017
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor ModelsMelinda Mata, Claudia Gerken, Phuong Nguyen, et al.
Pediatric Blood & Cancer|October 16, 2018
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinomaChristopher DeRenzo, Catherine Lam, Carlos Rodriguez-Galindo, et al.
Cancer Gene Therapy|September 3, 2020
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumoursKenneth Hsu, Shiloh Middlemiss, Federica Saletta, et al.
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Cancer Discovery|February 10, 2021
A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell FunctionShannon Lange, Laurens G L Sand, Matthew Bell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Pediatric Blood & Cancer|May 5, 2025
Recurrent Immune-Effector Cell-Associated Neurotoxicity Syndrome With Atypical Manifestations after TisagenlecleucelDevin Murphy, Raja B Khan, Soniya N Pinto, et al.
Pageof 23

Showing results (61-70 of 227) with videos related to

Sort By:
Pageof 23
Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.
Blood Advances|July 3, 2025
Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation StudyJohn C Panetta, Aimee C Talleur, Swati Naik, et al.
JCI Insight|November 5, 2020
MyD88/CD40 signaling retains CAR T cells in a less differentiated stateBrooke Prinzing, Patrick Schreiner, Matthew Bell, et al.
Cancer Discovery|August 13, 2017
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor ModelsMelinda Mata, Claudia Gerken, Phuong Nguyen, et al.
Pediatric Blood & Cancer|October 16, 2018
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinomaChristopher DeRenzo, Catherine Lam, Carlos Rodriguez-Galindo, et al.
Cancer Gene Therapy|September 3, 2020
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumoursKenneth Hsu, Shiloh Middlemiss, Federica Saletta, et al.
Nature Biotechnology|February 2, 2023
Synapse-tuned CARs enhance immune cell anti-tumor activityPeter J Chockley, Jorge Ibanez-Vega, Giedre Krenciute, et al.
Cancer Discovery|February 10, 2021
A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell FunctionShannon Lange, Laurens G L Sand, Matthew Bell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cellsAnn Leen, Maheshika Ratnayake, Aaron Foster, et al.
Pediatric Blood & Cancer|May 5, 2025
Recurrent Immune-Effector Cell-Associated Neurotoxicity Syndrome With Atypical Manifestations after TisagenlecleucelDevin Murphy, Raja B Khan, Soniya N Pinto, et al.
Pageof 23